Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004 - PubMed (original) (raw)

Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004

Abigail Fraser et al. Gastroenterology. 2007 Dec.

Abstract

Background & aims: Nonalcoholic fatty liver disease (NAFLD) is a common cause of liver disease in children and adolescents. The majority of studies of NAFLD in children have been in select populations of the clinically obese. Study aims were to estimate the prevalence of elevated alanine aminotransferase (ALT, as a marker of NAFLD) in a general contemporary adolescent population and to identify leading risk factors for ALT elevation (>30 U/L).

Methods: We analyzed data of adolescent participants (aged 12-19 years; N = 5586) in the National Health and Nutrition Examination Survey 1999-2004, a representative sample of the civilian noninstitutionalized US population.

Results: The prevalence of elevated ALT levels (>30 U/L) was 7.4% among white adolescents, 11.5% among Mexican American adolescents, and 6.0% among black adolescents. Elevated ALT levels were prevalent in 12.4% of male subjects compared with 3.5% of female subjects. Multivariable associations with elevated ALT levels were found for sex (odds ratio [OR] male vs female, 7.7; 95% confidence interval [CI], 3.9-15.1), ethnicity (OR black vs white, 0.6; 95% CI, 0.3-1.3; OR Mexican American vs white, 1.6; 95% CI, 1.0-2.6), waist circumference (OR per 1 SD, 1.4; 95% CI, 1.0-2.0), and fasting insulin level (OR per 1 SD, 1.6; 95% CI, 1.2-2.1). Age, C-reactive protein levels, and triglyceride levels were also positively and socioeconomic position inversely associated with elevated ALT levels. The magnitude of associations were similar across ethnic groups.

Conclusions: ALT level is associated with waist circumference and insulin resistance even in a young population. These characteristics could be utilized to identify adolescents who may benefit from screening for NAFLD, offering an opportunity to prevent disease progression at an early age.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement

No conflict of interest exists.

Figures

Figure 1

Figure 1

Prevalence of elevated ALT (>30 U/L) by ethnic group and sex

References

    1. Day CP. Liver Disease. Non-alcoholic fatty liver disease: current concepts and management strategies. Clinical Medicine. 2006;6:19–26. - PMC - PubMed
    1. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology. 1999;116:1413–1419. - PubMed
    1. Diehl AM. Hepatic complications of obesity. Gastroenterol Clin North Am. 2005;34:45–61. - PubMed
    1. Sathya P, Martin S, Alvarez F. Nonalcoholic fatty liver disease (NAFLD) in children. Curr Opin Pediatr. 2002;14:593–600. - PubMed
    1. Sokol RJ. The chronic disease of childhood obesity: the sleeping giant has awakened. J Pediatr. 2000;136:711–713. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources